Biomonde
Bridgend, Bridgend, United Kingdom
About Biomonde
BioMonde is a European wound care company specialising in the manufacture and distribution of larval debridement therapy (also known as maggot therapy) products for use in chronic and hard to heal wounds. Our state of the art pharmaceutical production units in the UK and Germany, together with our commitment to research, development and education, make BioMonde the first choice in wound debridement.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $11.1M
- Last round: Series Unknown (Mar 2015)
- Website: biomonde.com
- Phone: 448452301810
Industries & Categories
Health Care, Manufacturing, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/biomonde-2593672 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.